TVTX: Travere Therapeutics, Inc. 2021-12-15 07:00:00 Travere Therapeutics Announces Positive Topline Results from the Ongoing Phase 1/2 COMPOSE Study of Pegtibatinase in Classical Homocystinuria
Pupm&Dump trading strategy idea. $TVTX is rising too much today. The demand for shares of the company looks lower than the supply. This and other conditions can cause a fall in the share price today. So I opened a short position from $19,00; stop-loss — $20,50; take-profit — $16,02/MOC Do not view this idea as a recommendation for trading or investing. It is...
Gave you three entries and three exits. by iCantw84it 05.10.2021